Dennis M. Gross

1.4k total citations
26 papers, 519 citations indexed

About

Dennis M. Gross is a scholar working on Molecular Biology, Biochemistry and Physiology. According to data from OpenAlex, Dennis M. Gross has authored 26 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Biochemistry and 4 papers in Physiology. Recurrent topics in Dennis M. Gross's work include Eicosanoids and Hypertension Pharmacology (5 papers), Receptor Mechanisms and Signaling (5 papers) and Computational Drug Discovery Methods (3 papers). Dennis M. Gross is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (5 papers), Receptor Mechanisms and Signaling (5 papers) and Computational Drug Discovery Methods (3 papers). Dennis M. Gross collaborates with scholars based in United States, France and Belgium. Dennis M. Gross's co-authors include Charles S. Sweet, Herbert C. Wenger, David A. Weitz, E H Ulm, Backlund Eo, Carl T. Ludden, James W. Fisher, John J. Baldwin, J. W. Fisher and Stanley L. Gaul and has published in prestigious journals such as Analytical Biochemistry, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Dennis M. Gross

25 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dennis M. Gross United States 13 278 184 97 84 58 26 519
Kazuo Nunoki Japan 14 508 1.8× 166 0.9× 188 1.9× 79 0.9× 95 1.6× 37 860
Duncan Armstrong United Kingdom 13 279 1.0× 200 1.1× 141 1.5× 30 0.4× 30 0.5× 20 744
Giovanna Santini Italy 12 265 1.0× 139 0.8× 46 0.5× 91 1.1× 18 0.3× 18 884
Priska Kaufmann Switzerland 13 307 1.1× 151 0.8× 27 0.3× 94 1.1× 35 0.6× 36 777
Thomas L. Waldron United States 12 177 0.6× 190 1.0× 46 0.5× 99 1.2× 91 1.6× 25 473
Tadashi Iso Japan 11 247 0.9× 115 0.6× 40 0.4× 52 0.6× 27 0.5× 55 473
Holger Heitsch Germany 13 277 1.0× 436 2.4× 37 0.4× 72 0.9× 229 3.9× 20 756
Iftekhar Alam United States 12 255 0.9× 55 0.3× 85 0.9× 154 1.8× 41 0.7× 19 740
P C Wong United States 8 294 1.1× 343 1.9× 73 0.8× 39 0.5× 181 3.1× 10 579
Robert A. Vukovich United States 9 549 2.0× 623 3.4× 96 1.0× 74 0.9× 192 3.3× 19 1.1k

Countries citing papers authored by Dennis M. Gross

Since Specialization
Citations

This map shows the geographic impact of Dennis M. Gross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis M. Gross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis M. Gross more than expected).

Fields of papers citing papers by Dennis M. Gross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis M. Gross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis M. Gross. The network helps show where Dennis M. Gross may publish in the future.

Co-authorship network of co-authors of Dennis M. Gross

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis M. Gross. A scholar is included among the top collaborators of Dennis M. Gross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis M. Gross. Dennis M. Gross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boni, A.A., et al.. (2021). Companies Recognized as Innovators for 2021. Journal of Commercial Biotechnology. 26(2). 2 indexed citations
2.
Silverman, Ian M., Jennine M. Dawicki-McKenna, David W. Frederick, et al.. (2015). Evaluating the Success of the Small Business Innovation Research (SBIR) Program: Impact on Biotechnology Companies in Pennsylvania. 2(1). 4–13. 2 indexed citations
3.
Fisher, James W., Dennis M. Gross, James E. Foley, et al.. (2015). A Concept for the Control of Kidney Production of Erythropoietin Involving Prostaglandins and Cyclic Nucleotides. Contributions to nephrology. 13. 37–59.
4.
Baldwin, John J., Marcia E. Christy, Charles N. Habecker, et al.. (1986). .beta.1-Selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted amino)-2-hydroxypropoxy]phenyl]imidazole class. II. Journal of Medicinal Chemistry. 29(6). 1065–1080. 18 indexed citations
5.
Sweet, Charles S., et al.. (1984). Structure-activity studies with angiotensin converting enzyme inhibitors related to enalapril and MK-521.. 36–46. 1 indexed citations
6.
Huang, Leeyuan, et al.. (1984). Discovery, purification and characterization of the angiotensin converting enzyme inhibitor, L-681,176, produced by Streptomyces sp. MA 5143a.. The Journal of Antibiotics. 37(5). 462–465. 15 indexed citations
7.
Share, N. N., Victor J. Lotti, P. Gautheron, et al.. (1984). R-Enantiomer of timolol: a potential selective ocular antihypertensive agent. Graefe s Archive for Clinical and Experimental Ophthalmology. 221(5). 234–238. 10 indexed citations
8.
Schmitt, Claude, Dennis M. Gross, & N. N. Share. (1984). β-Adrenergic receptor subtypes in iris-ciliary body of rabbits. Graefe s Archive for Clinical and Experimental Ophthalmology. 221(4). 167–170. 16 indexed citations
9.
Baldwin, John J., Ralph Hirschmann, Mark B. Freedman, et al.. (1983). ChemInform Abstract: β1‐SELECTIVE ADRENOCEPTOR ANTAGONISTS: EXAMPLES OF THE 2‐(4‐(3‐(SUBSTITUTED‐AMINO)‐2‐HYDROXYPROPOXY)PHENYL)IMIDAZOLE CLASS. Chemischer Informationsdienst. 14(48). 1 indexed citations
10.
Gross, Dennis M. & David A. Weitz. (1982). An automated data acquisition system for isolated tissue studies. Journal of Pharmacological Methods. 8(2). 151–159. 2 indexed citations
11.
Baldwin, John J., D. E. MCCLURE, Dennis M. Gross, & Michael Williams. (1982). Use of (S)-(trifloxymethyl)oxirane in the synthesis of a chiral .beta.-adrenoceptor antagonist, (R)- and (S)-9-[[3-(tert-butylamino)-2-hydroxypropyl]oximino]fluorene. Journal of Medicinal Chemistry. 25(8). 931–936. 22 indexed citations
12.
Sweet, Charles S., et al.. (1981). Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats. European Journal of Pharmacology. 76(2-3). 167–176. 35 indexed citations
13.
Gross, Dennis M., Charles S. Sweet, E H Ulm, et al.. (1981). Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.. Journal of Pharmacology and Experimental Therapeutics. 216(3). 552–557. 136 indexed citations
14.
Sweet, Charles S., et al.. (1981). Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor.. Journal of Pharmacology and Experimental Therapeutics. 216(3). 558–566. 105 indexed citations
15.
Gross, Dennis M. & James W. Fisher. (1980). Erythropoietic effects of PGE2 and 2 endoperoxide analogs. Cellular and Molecular Life Sciences. 36(4). 458–459. 2 indexed citations
16.
Gross, Dennis M., et al.. (1979). Influence of albuterol on erythropoietin production and erythroid progenitor cell activation. American Journal of Physiology-Heart and Circulatory Physiology. 236(3). H422–H426. 7 indexed citations
17.
Foley, James E., et al.. (1978). The effects of arachidonic acid on erythropoietin production in exhypoxic polycythemic mice and the isolated perfused canine kidney.. Journal of Pharmacology and Experimental Therapeutics. 207(2). 402–409. 12 indexed citations
18.
Gross, Dennis M., J. Brookins, Gregory D. Fink, & James W. Fisher. (1976). Effects of prostaglandins A2, E2 and F2 alpha on erythropoietin production.. Journal of Pharmacology and Experimental Therapeutics. 198(2). 489–496. 28 indexed citations
19.
Gross, Dennis M., et al.. (1976). Enhanced Erythropoietin and Prostaglandin E Production in the Dog following Renal Artery Constriction. Experimental Biology and Medicine. 151(3). 498–501. 14 indexed citations
20.
Wells, John R., et al.. (1972). A reorienting density gradient rotor for zonal centrifugation. Analytical Biochemistry. 46(1). 7–18. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuo Nunoki Breakdown of academic impact, for papers by Duncan Armstrong Breakdown of academic impact, for papers by Giovanna Santini Breakdown of academic impact, for papers by Priska Kaufmann Breakdown of academic impact, for papers by Thomas L. Waldron Breakdown of academic impact, for papers by Tadashi Iso Breakdown of academic impact, for papers by Holger Heitsch Breakdown of academic impact, for papers by Iftekhar Alam Breakdown of academic impact, for papers by P C Wong Breakdown of academic impact, for papers by Robert A. Vukovich
Rankless by CCL
2026